• Cellceutix Initiates Dose Escalation in Phase 2 Trial of Brilacidin for Ulcerative Proctitis
  • NIH Awards $10M to Cedars-Sinai for Pioneering Research in IBD
  • Drug May Aid in Diagnosing via Scans IBD and Other Inflammatory Diseases
  • Traveling with Hope and Crohn’s Disease
  • IBD Patients, Especially Those with Crohn’s, at Higher Risk of Thyroid Cancer, Study Finds
  • FDA Grants Orphan Drug Status to AbbVie’s Therapy for Pediatric Crohn’s Disease
  • 1st Patient Enrolls in Phase 2 Study of Oral Therapy, OPRX-106, for Ulcerative Colitis
  • Galapagos Starts Phase 3 Trial of Filgotinib for Crohn’s Disease
  • NFL Suspends Buffalo Bills Player for Using Medical Marijuana to Treat Crohn’s Pain
  • My Love/Hate Relationship with Prednisone
  • Researchers Use Blood Test to Identify DNA Changes, Improve Diagnosis in IBD Patients
  • Vifor Supports Efforts to Make Public More Aware of Iron Deficiency and Its Health Impact